PRA International Webinar & Audioconferences

PRA Audio Conferences

Clinical Trial Site and Patient Recruitment — The Future Is Here
22-July-2010  |  11:30am (EDT)
Kent Thoelke, Senior VP Scientific and Medical Affairs, PRA International
Click here to register.

Recent Perspectives on Trial Design — Minimizing Patients for Oncology Trials
26-May-2010  |  11:30am - 12:30pm (EDT)
John Constant, PhD, VP Scientific Affairs, PRA International

Establishing Value for Diagnostics & Biomarkers in a Real-Life Setting
23-Feb-2010  |  11:30am - 12:30pm (EST)
Jerome Wilson, PhD, Sr. Scientific Affairs Director, PRA Late Phase Services
Kathleen Kushner, MPH, RN, Scientific Affairs Director, PRA Late Phase Services
To receive a recording of the above webinar - please send a request to: endpoints@praintl.com.

Clinical Trials: Why is India Irresistible?
28-Jan-2010  |  11:30am - 12:30pm (EST)
Pramod Kabra, MD
Director Clinical Operations PRA International, India

Studies in Special Patient Populations: More Than Just a Regulatory Requirement
29 Oct 2009  |  11:30 AM (EST)
Christian Reh, MD, PhD
Vice President, Clinical Affairs, Early Development Services

Current Trends in Clinical Neuroscience: A Focus on Multiple Sclerosis
1 Oct 2009
Stephen Peroutka, MD, PhD
Vice President Neurosciences, Scientific Affairs

From Emerging to Emerged - Clinical Development in Asia-Pacific
2 Sep 2009
Edward C. Ian
Senior Director of Clinical Operations, Asia-Pacific, PRA

Oncology Trials in 2009: Challenges and Innovative Approaches
28 Jul 2009
Ute Berger, MD
Vice President and Head of Medical Affairs, Europe, Africa & Asia-Pacific

Blending REMS Science with Operational Execution
16 Jun 2009
Jerome Wilson, PhD
Senior Scientific Affairs Director, Late Phase Services
Kathleen Kushner, MPH, RN
Scientific Affairs Director, Late Phase Services
Mark Nelson Tyrrell, B.S., R.P.H.
Director, Safety and Risk Management

Adaptive/Novel Designs in Oncology: Overview and Issues
19 May 2009
John Constant, PhD
Vice President, Scientific Affairs, Statistical Consulting, Oncology/Hematology

Phase I Studies with Hepatitis C Compounds in Healthy Volunteers and Patients – views from inside
14 Apr 2009
Andre van Vliet, MD, PhD
Vice President, Medical Affairs, EDS

Beyond Global Feasibility: An Evidenced Based Approach to Creating Realistic Development Time Lines
25 Mar 2009
Kent Thoelke
Sr. Vice President, Therapeutic Expertise

Optimizing Country Selection for Clinical Research
14 Feb 2008
Dr. Susan Stansfield
Executive Vice President, Product Registration – Europe, Africa and Asia-Pacific

For media relations requests and information please click here.